Form 4: Chemed Corp Executive Brian C. Judkins Reports Stock Transactions

Brian C. Judkins, VP and Chief Legal Officer of Chemed Corp, reports the acquisition and disposal of Chemed Corp capital stock and stock options on March 20, 2024.

Summary

• On March 20, 2024, Brian C. Judkins, VP and Chief Legal Officer of Chemed Corp, reported transactions involving Chemed Corp's capital stock and stock options.
• Judkins acquired 5,825 shares of capital stock at $413.19 and 6,133 shares at $471.74 through the exercise of stock options.
• He also disposed of 11,158 shares of capital stock at an average price of $645, with prices ranging from $642.00 to $649.00.
• Following these transactions, Judkins directly owns 1,422 shares of capital stock and 52,233 derivative securities.
• The stock options are rights to buy capital stock with tandem tax withholding.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the buying and selling activities of company executives. It is a standard practice required by the SEC to prevent insider trading and maintain market fairness.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders, ensuring compliance with SEC regulations.
• The transactions reported are typical for executives who receive stock options as part of their compensation packages.
• Comparable companies such as Amedisys and LHC Group also have similar insider transaction reporting requirements.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• It helps maintain investor confidence by ensuring compliance with securities regulations.

Key Dates